Neuronetics, Inc. financial data

Symbol
STIM on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
3222 Phoenixville Pike, Malvern, PA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 408 % +0.75%
Quick Ratio 38.9 % -3.07%
Debt-to-equity 244 % +130%
Return On Equity -109 % -86.1%
Return On Assets -31.7 % -11.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30.3M shares +4.93%
Common Stock, Shares, Outstanding 30.1M shares +4.59%
Entity Public Float 56.5M USD -16.5%
Common Stock, Value, Issued 301K USD +4.51%
Weighted Average Number of Shares Outstanding, Basic 30.1M shares +5.11%
Weighted Average Number of Shares Outstanding, Diluted 30.1M shares +5.11%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 72.1M USD +6.22%
Research and Development Expense 8.95M USD -15.9%
Selling and Marketing Expense 47.8M USD +1.47%
General and Administrative Expense 24.7M USD -3.41%
Operating Income (Loss) -28.7M USD +11.6%
Net Income (Loss) Attributable to Parent -32.5M USD -3.68%
Earnings Per Share, Basic -1.1 USD/shares +2.66%
Earnings Per Share, Diluted -1.1 USD/shares +2.66%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 42.6M USD -7.11%
Accounts Receivable, after Allowance for Credit Loss, Current 17.1M USD +30.4%
Inventory, Net 6.14M USD -30.8%
Assets, Current 75.5M USD -2.79%
Property, Plant and Equipment, Net 1.73M USD -18%
Operating Lease, Right-of-Use Asset 2.48M USD -18.8%
Other Assets, Noncurrent 5.05M USD +25%
Assets 96.8M USD -3.57%
Accounts Payable, Current 4.1M USD -0.99%
Accrued Liabilities, Current 9.24M USD +10.3%
Liabilities, Current 29.3M USD +94.7%
Operating Lease, Liability, Noncurrent 2.01M USD -24.6%
Liabilities 77.4M USD +41%
Retained Earnings (Accumulated Deficit) -394M USD -8.99%
Stockholders' Equity Attributable to Parent 19.4M USD -57.4%
Liabilities and Equity 96.8M USD -3.57%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12M USD +21%
Net Cash Provided by (Used in) Financing Activities 499K USD
Net Cash Provided by (Used in) Investing Activities 68K USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 30.1M shares +4.59%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 42.6M USD -7.11%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.67M USD +56.6%
Deferred Tax Assets, Valuation Allowance 94.5M USD +8.92%
Deferred Tax Assets, Gross 98.9M USD +8.89%
Operating Lease, Liability 2.86M USD -18.1%
Lessee, Operating Lease, Liability, to be Paid 3.26M USD -20.9%
Property, Plant and Equipment, Gross 4.9M USD -10.5%
Operating Lease, Liability, Current 856K USD +2.64%
Lessee, Operating Lease, Liability, to be Paid, Year Two 921K USD +2.56%
Lessee, Operating Lease, Liability, to be Paid, Year One 898K USD +2.63%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 393K USD -36.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 882K USD -4.24%
Deferred Tax Assets, Operating Loss Carryforwards 82.2M USD +8.11%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 116K USD -86.8%
Operating Lease, Payments 275K USD +3%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 560K USD +8.53%
Deferred Tax Assets, Net of Valuation Allowance 4.38M USD +8.06%
Share-based Payment Arrangement, Expense 6.38M USD -21.5%
Interest Expense 6.83M USD +46.3%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%